News
ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic ...
Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...
The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
On Thursday’s episode of Mad Money, host Jim Cramer turned his focus to large-cap stocks that surged by $10 or more in a single day.
Analysts are all over Eli Lilly, and most suggest a "Moderate Buy." Sixteen analysts recommend buying, while three say "hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results